首页|First Affiliated Hospital of Nanjing Medical University Reports Findings in Blad der Cancer (MRI-Based Machine Learning Radiomics for Preoperative Assessment of Human Epidermal Growth Factor Receptor 2 Status in Urothelial Bladder Carcinoma)

First Affiliated Hospital of Nanjing Medical University Reports Findings in Blad der Cancer (MRI-Based Machine Learning Radiomics for Preoperative Assessment of Human Epidermal Growth Factor Receptor 2 Status in Urothelial Bladder Carcinoma)

扫码查看
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Oncology - Bladder Can cer is the subject of a report. According to news reporting originating in Nanji ng, People’s Republic of China, by NewsRx journalists, research stated, “The hum an epidermal growth factor receptor 2 (HER2) has recently emerged as hotspot in targeted therapy for urothelial bladder cancer (UBC). The HER2 status is mainly identified by immunohistochemistry (IHC), preoperative and noninvasive methods f or determining HER2 status in UBC remain in searching.” Financial support for this research came from National Natural Science Foundatio n of China.

NanjingPeople’s Republic of ChinaAsiaBladder CancerCancerCarcinomasCyborgsEmerging TechnologiesGrowth Fa ctor ReceptorsHealth and MedicineMachine LearningMembrane ProteinsOncologyPeptide Receptors

2024

Robotics & Machine Learning Daily News

Robotics & Machine Learning Daily News

ISSN:
年,卷(期):2024.(Mar.22)